company background image
USAQ logo

QHSLab OTCPK:USAQ Stock Report

Last Price

US$0.17

Market Cap

US$1.8m

7D

16.0%

1Y

480.0%

Updated

04 Nov, 2024

Data

Company Financials

USAQ Stock Overview

A medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine.

USAQ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

QHSLab, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for QHSLab
Historical stock prices
Current Share PriceUS$0.17
52 Week HighUS$0.35
52 Week LowUS$0.015
Beta-0.63
11 Month Change45.12%
3 Month Change-13.00%
1 Year Change480.00%
33 Year Change-74.41%
5 Year Change85.11%
Change since IPO-99.99%

Recent News & Updates

Recent updates

Shareholder Returns

USAQUS Medical EquipmentUS Market
7D16.0%0.3%-1.9%
1Y480.0%25.8%30.4%

Return vs Industry: USAQ exceeded the US Medical Equipment industry which returned 25.8% over the past year.

Return vs Market: USAQ exceeded the US Market which returned 30.8% over the past year.

Price Volatility

Is USAQ's price volatile compared to industry and market?
USAQ volatility
USAQ Average Weekly Movement41.1%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.9%

Stable Share Price: USAQ's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: USAQ's weekly volatility has decreased from 71% to 41% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
19834Troy Groganwww.usaqcorp.com

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians.

QHSLab, Inc. Fundamentals Summary

How do QHSLab's earnings and revenue compare to its market cap?
USAQ fundamental statistics
Market capUS$1.83m
Earnings (TTM)-US$190.49k
Revenue (TTM)US$1.61m

1.1x

P/S Ratio

-9.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
USAQ income statement (TTM)
RevenueUS$1.61m
Cost of RevenueUS$653.05k
Gross ProfitUS$960.04k
Other ExpensesUS$1.15m
Earnings-US$190.49k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.018
Gross Margin59.52%
Net Profit Margin-11.81%
Debt/Equity Ratio-436.7%

How did USAQ perform over the long term?

See historical performance and comparison